NDC 60687-252-40 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60687-252
- Requested NDC
- 60687-252-40
- Package NDCs from labels
- 60687-252-40, 60687-252-46, 60687-252-86
- Manufacturer
- American Health Packaging
- Effective date
- 2026-06-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - American Health Packaging | American Health Packaging | 2026-06-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60687-252-40 | Ondansetron | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 10 | |
| 60687-252-46 | Ondansetron | 10 in 1 TRAY | SOLUTION | 10 | 10 | |
| 60687-252-86 | Ondansetron | 3 in 1 CASE | SOLUTION | 3 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60687-252-40 | ML - Milliliter | 60687-252 | fff1e0d4-f8fc-41ab-9408-bee8420c5db1 | 1 | 2019-02-13 |
| 60687-252-46 | ML - Milliliter | 60687-252 | f339fc5c-dfb6-4593-83b5-71e2ea605b09 | 1 | 2019-02-13 |
| 60687-252-86 | ML - Milliliter | 60687-252 | 29cfca47-9dfd-4852-9f12-f8fb32ce50a3 | 1 | 2019-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| La Roche Posay Laboratoire Dermatologique Cicaplast Defense B5 | GLYCERIN | Cosmetique Active Production | 01c8a0d5-bcd1-4639-be45-530a226401f0 | 2023-12-11 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Pain Relief Cream | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | WALGREENS | 03bbe146-f185-bcfa-e063-6394a90a85bf | 2023-12-04 | Warnings | PDC6A3C0OX |
| Eye Wash | WATER | Jiangxi Zhenmei Biological Technology Co.,Ltd | c68795b8-bf68-0d01-e053-2a95a90abebb | 2023-12-04 | Warnings | 059QF0KO0R |
| Bloop Hemorrhoid Relief Topical | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | Three Nations Corp | 0b6419e3-f1c7-bdfe-e063-6294a90a5d92 | 2023-11-30 | Warnings | PDC6A3C0OX |
| Ondansetron | ONDANSETRON HYDROCHLORIDE | Fresenius Kabi USA, LLC | 6a231919-6837-4b09-b66d-3706432b9702 | 2023-11-20 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON HYDROCHLORIDE | Fresenius Kabi USA, LLC | e0050959-c14c-41b6-9a92-fadc5f6feff3 | 2023-11-02 | Warnings, Adverse reactions | NMH84OZK2B |
| Sodium phenylacetate and Sodium benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Zydus Pharmaceuticals USA Inc. | 0f17c50f-3761-4470-bf3b-63837a287b8a | 2023-10-30 | Warnings, Adverse reactions | OJ245FE5EU |
| Family Wellness | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, PETROLATUM | FRONT PHARMACEUTICAL PLC | eb1785f4-5876-443b-b175-9b59d65d1a48 | 2023-10-26 | Warnings | PDC6A3C0OX |
| CVS Health Hemorrhoidal Cream | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | FRONT PHARMACEUTICAL PLC | cb448d78-553c-4e65-80c5-d4b31d7b3661 | 2023-10-26 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Cream | GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, WHITE PETROLATUM | Cardinal Health 110, LLC. dba Leader | 85a51d5c-679e-1959-e053-2a91aa0a76d5 | 2023-10-25 | Warnings | PDC6A3C0OX |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | A-S Medication Solutions | 674ea285-8f84-4603-9655-82200c523fe5 | 2023-10-25 | Warnings, Adverse reactions | NMH84OZK2B |
| Family Wellness | GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, PETROLATUM | Zhejiang Jingwei Pharmaceutical Co., Ltd. | fde9cd90-d63c-4058-b46e-511fecea36ec | 2023-10-24 | Warnings | PDC6A3C0OX |
| Eyeganics Organic Tears | GLYCERIN | Eyeganics LLC | 42470af7-a3ae-4e14-88e0-04cd92db4b37 | 2023-10-13 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Pain Relief with Aloe and VitaminE | HEMORRHOIDAL PAIN RELIEF WITH ALOE AND VITAMINE | NeilMed pharmaceuticals Inc. | 076b5021-8ba0-0204-e063-6294a90a3337 | 2023-10-11 | Warnings | PDC6A3C0OX |
| Metab | CALCAREA SULPHURICA, KALI MURIATICUM, KALI PHOSPHORICUM, KALI SULPHURICUM, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NATRUM SULPHURICUM, CEREBELLUM (SUIS), GALLBLADDER (BOVINE), HEART (BOVINE), HEPAR (BOVINE), HYPOTHALAMUS SUIS, INTESTINE (SUIS), KIDNEY (BOVINE), LUNG (BOVINE), MEDULLA OSSIS SUIS, PANCREAS SUIS, PINEAL GLAND (SUIS), RECTAL MUCOSA (SUIS), SPLEEN (BOVINE), STOMACH (SUIS), THYMUS (OVINE), THYROIDINUM (BOVINE), URINARY BLADDER (SUIS), PITUITARUM POSTERIUM (BOVINE), ACETYL COENZYME A, | Nutritional Specialties, Inc. | bbed9973-238f-47c5-9a50-ac0869a7eb3a | 2023-10-09 | Warnings | XF417D3PSL |
| ONDANSETRON | ONDANSETRON | Chartwell RX, LLC | 88b7432b-f5a7-40f3-9b0c-e7b125f5103c | 2023-10-05 | Warnings, Adverse reactions | NMH84OZK2B |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | PDC6A3C0OX 059QF0KO0R |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | PDC6A3C0OX 059QF0KO0R XF417D3PSL |
| AnubisMed | AZELAIC ACID, SALICYLIC ACID | ANUBIS COSMETICS SL | ebf3153d-30f5-54e4-e053-2995a90a74b1 | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | GLYCOLIC ACID, CITRIC ACID, LACTIC ACID, KOJIC ACID | ANUBIS COSMETICS SL | eca95dde-cb57-2ab6-e053-2995a90af84f | 2023-09-05 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.